0001660410-21-000001.txt : 20210614 0001660410-21-000001.hdr.sgml : 20210614 20210614114814 ACCESSION NUMBER: 0001660410-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210614 DATE AS OF CHANGE: 20210614 EFFECTIVENESS DATE: 20210614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ribon Therapeutics, Inc. CENTRAL INDEX KEY: 0001660410 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473651475 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-402745 FILM NUMBER: 211013791 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-914-8700 MAIL ADDRESS: STREET 1: 35 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 D 1 primary_doc.xml X0708 D LIVE 0001660410 Ribon Therapeutics, Inc. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA MASSACHUSETTS 02140 617-914-8700 DELAWARE None None Corporation true Svennilson Peter 35 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Director Victoria M. Richon 35 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Executive Officer Director Jonathan Root 35 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Director Cameron Wheeler 35 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Director Emma Reeve 35 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Director James Audia 35 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Director Marian Nakada 35 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Director Jodie Morrison 35 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Director Laura Brass 35 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Director Edward Stewart 35 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Executive Officer Biotechnology Decline to Disclose 06b false 2021-06-01 false true false 0 60150139 25150140 34999999 false 16 0 0 0 false Ribon Therapeutics, Inc. /s/ Victoria M. Richon, Ph.D. Victoria M. Richon, Ph.D. President and Chief Executive Officer 2021-06-14